Renaissance Capital logo

Living Homeopathy International Filed Terms, Nasdaq: LHI

Sells homeopathic products in Hong Kong.

Industry: Consumer Staples

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: Consumer Staples

We are a Hong Kong-based homeopathy service provider committed to providing customers with access to quality homeopathy resources as alternative treatment to enhance holistic health and wellness. Among all the homeopathy service providers in Hong Kong, we are ranked first by market share of approximately 41.3% in terms of homeopathic products sales revenue generated in Hong Kong in 2023, according to Frost & Sullivan. Our products consist of homeopathic remedies, homeopathic co-remedies, classical flower remedies, personal care products, and water filter and related products. We categorize homeopathic remedies, homeopathic co-remedies and classical flower remedies as our healthcare products. With respect to our healthcare products, we globally procure homeopathic remedies, homeopathic co-remedies and classical flower remedies that are manufactured by our selected homeopathic products manufacturers and meet our specific product requirements. We label the products under our brand name “LIVING” and sell them in the Hong Kong market.
more less
IPO Data
IPO File Date 05/23/2025
Offer Price
Price Range $4.00 - $6.00
Offer Shares (mm) 1.3
Deal Size ($mm) $6
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date
Offer Price
Price Range $4.00 - $6.00
Offer Shares (mm) 1.3
Deal Size ($mm) $6
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Revere Securities
Craft Capital Management
Company Data
Headquarters Hong Kong, China
Founded 1994
Employees at IPO 16
Website www.living-homeopathy.com

Living Homeopathy International (LHI) Performance